HBV Mutation Detail Information

> L180M Search Result


Mutation Information
Mutation Site L180M
Mutation Type Amino acid level
Gene/Protein/Region Type RT
Combined Mutation rt.V173L+rt.M204V+rt.L180M
Relevant Drug lamivudine (LAM)
Country Germany
Literature Information
PubMed PMID 16871563
Clinical information Yes
Disease Chronic hepatitis B
Published Year 2006
Journal Hepatology (Baltimore, Md.)
Title Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy.
Author van Bömmel F,Zöllner B,Sarrazin C,Spengler U,Hüppe D,Möller B,Feucht HH,Wiedenmann B,Berg T
Evidence Lamivudine-associated mutations (rtV173L, rtL180M, rtM204V/I) could be detected in 6 patients at baseline of TDF, but this obviously did not influence the response.

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation